These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12827450)

  • 1. Point mutations in exon 1 of the NR4A2 gene are not a major cause of familial Parkinson's disease.
    Zimprich A; Asmus F; Leitner P; Castro M; Bereznai B; Homann N; Ott E; Rutgers AW; Wieditz G; Trenkwalder C; Gasser T
    Neurogenetics; 2003 Aug; 4(4):219-20. PubMed ID: 12827450
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations in NR4A2 associated with familial Parkinson disease.
    Le WD; Xu P; Jankovic J; Jiang H; Appel SH; Smith RG; Vassilatis DK
    Nat Genet; 2003 Jan; 33(1):85-9. PubMed ID: 12496759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nurr1 mutational screen in Parkinson's disease.
    Tan EK; Chung H; Chandran VR; Tan C; Shen H; Yew K; Pavanni R; Puvan KA; Wong MC; Teoh ML; Yih Y; Zhao Y
    Mov Disord; 2004 Dec; 19(12):1503-5. PubMed ID: 15390059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of NR4A2 exon 1 mutations in 108 families with autosomal dominant Parkinson disease.
    Ibáñez P; Lohmann E; Pollak P; Durif F; Tranchant C; Agid Y; Dürr A; Brice A;
    Neurology; 2004 Jun; 62(11):2133-4. PubMed ID: 15184637
    [No Abstract]   [Full Text] [Related]  

  • 5. Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study.
    Karamohamed S; Golbe LI; Mark MH; Lazzarini AM; Suchowersky O; Labelle N; Guttman M; Currie LJ; Wooten GF; Stacy M; Saint-Hilaire M; Feldman RG; Liu J; Shoemaker CM; Wilk JB; DeStefano AL; Latourelle JC; Xu G; Watts R; Growdon J; Lew M; Waters C; Vieregge P; Pramstaller PP; Klein C; Racette BA; Perlmutter JS; Parsian A; Singer C; Montgomery E; Baker K; Gusella JF; Herbert A; Myers RH
    Mov Disord; 2005 Sep; 20(9):1188-91. PubMed ID: 15966003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translated mutation in the Nurr1 gene as a cause for Parkinson's disease.
    Grimes DA; Han F; Panisset M; Racacho L; Xiao F; Zou R; Westaff K; Bulman DE
    Mov Disord; 2006 Jul; 21(7):906-9. PubMed ID: 16532445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease.
    Hering R; Petrovic S; Mietz EM; Holzmann C; Berg D; Bauer P; Woitalla D; Müller T; Berger K; Krüger R; Riess O
    Neurology; 2004 Apr; 62(7):1231-2. PubMed ID: 15079038
    [No Abstract]   [Full Text] [Related]  

  • 8. NR4A2 genetic variation in sporadic Parkinson's disease: a genewide approach.
    Healy DG; Abou-Sleiman PM; Ahmadi KR; Gandhi S; Muqit MM; Bhatia KP; Quinn NP; Lees AJ; Holton JL; Revesz T; Wood NW
    Mov Disord; 2006 Nov; 21(11):1960-3. PubMed ID: 16977628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the role of Nurr1 in a large sample of familial Parkinson's disease.
    Nichols WC; Uniacke SK; Pankratz N; Reed T; Simon DK; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T;
    Mov Disord; 2004 Jun; 19(6):649-55. PubMed ID: 15197702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NR4A2 mutations are rare among European patients with familial Parkinson's disease.
    Wellenbrock C; Hedrich K; Schäfer N; Kasten M; Jacobs H; Schwinger E; Hagenah J; Pramstaller PP; Vieregge P; Klein C
    Ann Neurol; 2003 Sep; 54(3):415. PubMed ID: 12953278
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular mechanisms of dopaminergic neurodegeneration: genetic and environmental basis.
    Imam SZ
    Ann N Y Acad Sci; 2003 May; 993():377; discussion 387-93. PubMed ID: 12853331
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of Nurr1 nucleotide variations in familial Parkinson's disease.
    Levecque C; Destée A; Mouroux V; Amouyel P; Chartier-Harlin MC
    Neurosci Lett; 2004 Aug; 366(2):135-8. PubMed ID: 15276233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of a novel NR4A2 mutation in Parkinson's disease brain.
    Sleiman PM; Healy DG; Muqit MM; Yang YX; Van Der Brug M; Holton JL; Revesz T; Quinn NP; Bhatia K; Diss JK; Lees AJ; Cookson MR; Latchman DS; Wood NW
    Neurosci Lett; 2009 Jun; 457(2):75-9. PubMed ID: 19429166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Nurr1 pathway for neuroprotection.
    Bensinger SJ; Tontonoz P
    Cell; 2009 Apr; 137(1):26-8. PubMed ID: 19345183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NR4A2 controls the differentiation of selective dopaminergic nuclei in the zebrafish brain.
    Blin M; Norton W; Bally-Cuif L; Vernier P
    Mol Cell Neurosci; 2008 Dec; 39(4):592-604. PubMed ID: 18822380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering neurons for Parkinson's disease.
    Lindvall O
    Nat Biotechnol; 1999 Jul; 17(7):635-6. PubMed ID: 10409349
    [No Abstract]   [Full Text] [Related]  

  • 17. Nurr1 in Parkinson's disease and related disorders.
    Chu Y; Le W; Kompoliti K; Jankovic J; Mufson EJ; Kordower JH
    J Comp Neurol; 2006 Jan; 494(3):495-514. PubMed ID: 16320253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NR4A2 and schizophrenia: lack of association in a Portuguese/Brazilian study.
    Ruano D; Macedo A; Dourado A; Soares MJ; Valente J; Coelho I; Santos V; Azevedo MH; Goodman A; Hutz MH; Gama C; Lobato MI; Belmonte-de-Abreu P; Palha JA
    Am J Med Genet B Neuropsychiatr Genet; 2004 Jul; 128B(1):41-5. PubMed ID: 15211629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BCL2 code to dopaminergic development and Parkinson's disease.
    van der Heide LP; Smidt MP
    Trends Mol Med; 2013 Apr; 19(4):211-6. PubMed ID: 23523055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The research advance of nuclear receptor Nurr1].
    Lai YL; Xie ZP
    Sheng Li Ke Xue Jin Zhan; 2004 Apr; 35(2):177-80. PubMed ID: 15285431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.